The GM obtained from IBD patients showed poor ability to produce AhR ligands (23), and in addition, sterile mice susceptible to colitis observed significant improvement in intestinal inflammation after supplementation with AhR agonists and Lactobacillus strains capable of metabolizing tryptophan (22). This evidence concerns the gene AHR and inflammatory bowel disease.